CADTH is looking for volunteers to review abstracts submitted for presentation at the 2018 CADTH Symposium. This is a great way to participate in developing a stellar program, featuring relevant and engaging topics in a wide variety of formats: workshops, oral presentations, poster presentations,…
Read this month’s issue of New at CADTH. Here, you’ll find the latest information on our products and services, corporate news, and news flashes of upcoming events across Canada.
We are pleased to announce that nominations are now being accepted for the Dr. Maurice McGregor Award and Dr. Jill M. Sanders Award of Excellence in Health Technology Assessment, two prestigious awards for outstanding achievement in the field of health technology assessment in Canada.
Submit your…
Dr. Brian O’Rourke, CADTH President and Chief Executive Officer, is pleased to announce the appointment of four new members and a new chair to Canadian Drug Expert Committee (CDEC), and two new members and a new chair to its Health Technology Expert Review Panel (HTERP).
Canadian Drug Expert…
See CDR Update 128 for important news and information regarding the CADTH Common Drug Review.
CADTH is pleased to announce the 2018 CADTH Symposium Travel Award Program for students and patient group representatives.
Eligible students and patient group representatives can receive up to $2,000 to offset registration, travel, food, accommodation, and other conference-related expenses.
Travel…
Dr. Hakique Virani
Medical Director, Metro City Medical Clinic; and Assistant Clinical Professor, Department of Medicine, University of Alberta
There is no one face of Canada’s drug poisoning crisis— it affects all of us. Families and communities continue to be devastated by the loss of loved ones…
Read this month’s issue of New at CADTH. Here, you’ll find the latest information on our products and services, corporate news, and news flashes of upcoming events across Canada.
Event Date: October 3, 2017Location: Beanfield Centre, Room 204 ABC
105 Princes’ Blvd., Toronto, ON
The CADTH Drug Portfolio Information Sessions are an opportunity to receive an update on our drug portfolio, including CADTH’s Common Drug Review (CDR), pan-Canadian Oncology Drug Review (pCODR), and…
CADTH has completed its Therapeutic Review update of second-line therapies for patients with type 2 diabetes. The following reports are now available on the CADTH website:
final science report on second-line therapy (clinical and economic evaluations)
final recommendations report on second-line…
Delivering on our commitment to provide evidence and resources that support Canada’s response to the opioid crisis continues to be a key priority for CADTH.
Over the summer we’ve answered a range of research questions related to the treatment of opioid use disorder and the use of drug and non-drug…
The 2018 CADTH Symposium will be held in Halifax, Nova Scotia from April 15 to 17, 2018.
The theme is Managing Health Technologies: Supporting Appropriate, Affordable, and Accessible Care.
Submission Deadline: Friday, October 27, 2017.
Questions may be sent by email to [email protected].